Vijaya Diagnostic Centre Ltd
NSE:VIJAYA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Vijaya Diagnostic Centre Ltd
EPS (Diluted)
Vijaya Diagnostic Centre Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Vijaya Diagnostic Centre Ltd
NSE:VIJAYA
|
EPS (Diluted)
₹13
|
CAGR 3-Years
9%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Dr Agarwal's Eye Hospital Ltd
BSE:526783
|
EPS (Diluted)
₹144
|
CAGR 3-Years
31%
|
CAGR 5-Years
338%
|
CAGR 10-Years
50%
|
|
|
Thyrocare Technologies Ltd
NSE:THYROCARE
|
EPS (Diluted)
₹8
|
CAGR 3-Years
23%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
|
EPS (Diluted)
₹31
|
CAGR 3-Years
29%
|
CAGR 5-Years
17%
|
CAGR 10-Years
16%
|
|
|
Krsnaa Diagnostics Ltd
NSE:KRSNAA
|
EPS (Diluted)
₹23
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Metropolis Healthcare Ltd
NSE:METROPOLIS
|
EPS (Diluted)
₹8
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
Vijaya Diagnostic Centre Ltd
Glance View
In the bustling corridors of India's healthcare landscape, Vijaya Diagnostic Centre Ltd. stands as a beacon of precision and reliability. Founded in 1981 in Hyderabad, the company has grown from a single diagnostic center into a formidable network offering a wide array of testing services. With its roots firmly embedded in pathology and radiology, Vijaya combines state-of-the-art technology with a commitment to precision and accuracy, serving millions of patients across numerous locations. Every day, the company's centers buzz with activity as skilled technicians and medical professionals process a vast spectrum of tests and screenings, ranging from routine blood work to advanced imaging services. Vijaya Diagnostic Centre's business model is built upon delivering accurate diagnostic results efficiently, which forms the foundation of its revenue stream. As patients increasingly prioritize quality diagnostics for effective treatment, Vijaya ensures its services remain accessible across its widespread network. With the rising demand for healthcare services in India, paired with an increase in lifestyle-related ailments requiring regular monitoring, Vijaya positions itself strategically by continually expanding its reach and service offerings. Revenues pour in through direct patient payments and collaborations with medical institutions, cementing its role as a critical partner in preventive healthcare and diagnosis-driven wellness strategies.
See Also
What is Vijaya Diagnostic Centre Ltd's EPS (Diluted)?
EPS (Diluted)
13.9
INR
Based on the financial report for Mar 31, 2025, Vijaya Diagnostic Centre Ltd's EPS (Diluted) amounts to 13.9 INR.
What is Vijaya Diagnostic Centre Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
18%
Over the last year, the EPS (Diluted) growth was 20%. The average annual EPS (Diluted) growth rates for Vijaya Diagnostic Centre Ltd have been 9% over the past three years , 18% over the past five years .